<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>South East European Journal of Immunology Feed</title>
        <link>https://reference-global.com/journal/SEEJIM</link>
        <description>Reference Global RSS Feed for South East European Journal of Immunology</description>
        <lastBuildDate>Tue, 17 Nov 2026 00:21:16 GMT</lastBuildDate>
        <docs>https://validator.w3.org/feed/docs/rss2.html</docs>
        <generator>https://github.com/jpmonette/feed</generator>
        <image>
            <title>South East European Journal of Immunology Feed</title>
            <url>https://paradigm-files.s3.eu-central-1.amazonaws.com/SEEJIM/cover-image.jpg</url>
            <link>https://reference-global.com/journal/SEEJIM</link>
        </image>
        <copyright>All rights reserved 2026, Sciendo</copyright>
        <atom:link href="https://reference-global.com/2/rss/journal/SEEJIM" rel="self" type="application/rss+xml"/>
        <item>
            <title><![CDATA[Botanical Larvicide from Jeruk Limau (Citrus amblycarpa) and Serai (Cymbopogon citratus) for Killing Aedes aegypti Larvae]]></title>
            <link>https://reference-global.com/article/10.3889/seejim.2024.6073</link>
            <guid isPermaLink="false">/article/10.3889/seejim.2024.6073</guid>
            <pubDate>Fri, 07 Jun 2024 00:00:00 GMT</pubDate>
            <description><![CDATA[BACKGROUNDDengue hemorrhagic fever is caused by the dengue virus which is transmitted through the bite of the Aedes aegypti mosquito which breeds in densely populated areas with humid and warm climates. The use of anti-mosquito drugs in the form of burns, sprays, lotions, or other forms has been widely used, but these drugs are not completely profitable. Anticipatory efforts need to be made by utilizing natural materials so that they can be used effectively and safely for both humans and the environment.AIMOur study tries to find the effectivity of the infusion from Jeruk Limau (Citrus amblycarpa) and Serai for botanical larvicide against Aedes aegypti larvae.METHODSThis research is a pure experimental study with a Post-test Only Control Group Design by making larvicide products from lime and lemongrass waste infusions, the results of which are analyzed descriptively and analytically. The research used two factors, namely treatment (P) using infusion products whereas control (K) using distilled water.RESULTSFrom the results of effectiveness tests on larvae, it was found that there was a reduction in live larvae until all of them died. Lime and lemongrass waste contain flavonoid compounds which are respiratory toxins in larvae. The combination of saponin and tannin as a stomach poison has the power to kill mosquito larvae. The abundant availability of materials, enriching research treasures on local potential, as well as a good level of public acceptance are the advantages of the product.CONCLUSIONApart from that, it is recommended to optimize the dosage and durability of the product so that it can be further patented as a concrete step in realizing the sustainable development agenda in the health sector.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[Atopic Dermatitis as a Precursor to Early Onset of Recurrent Wheeze, Bronchiolitis, and Childhood Asthma]]></title>
            <link>https://reference-global.com/article/10.3889/seejim.2024.6078</link>
            <guid isPermaLink="false">/article/10.3889/seejim.2024.6078</guid>
            <pubDate>Fri, 07 Jun 2024 00:00:00 GMT</pubDate>
            <description><![CDATA[INTRODUCTIONChildhood asthma frequently escapes timely diagnosis, a consequence of inadequate parental education, societal prejudices, and health-care professionals’ limited knowledge. Bringing attention to atopic dermatitis (AD) as an early indicator of childhood asthma can enhance awareness about the elevated risk of recurrent wheezing, bronchiolitis, and asthma in children, thereby advancing their care and treatment.AIMThe objective of this study is to investigate the correlation between AD and the occurrence of recurrent wheezing, bronchiolitis, as well as asthma, in children aged 0–3 years. The findings of this research aim to contribute to early detection practices and guide the implementation of suitable treatment strategies for this vulnerable age group.MATERIALS AND METHODSIn this study, retrospective data were gathered from health records at the Pediatric Primary Health Care Practice - “Vitalino” in Veles, North Macedonia. The analysis encompassed 414 children aged 0–3 years, spanning the years 2019–2022. The primary focus of the investigation was on children exhibiting early- onset AD and its association with recurrent wheezing, as well as bronchiolitis and the development of early childhood asthma.RESULTSThe conducted statistical analyses, including measures such as prevalence, odds ratio, and multiple regression, revealed a significant association between AD and the early occurrence of recurrent wheezing. In addition, the analyses demonstrated a noteworthy association not only between AD and early recurrent wheezing but also between AD and childhood asthma. Moreover, a significant connection was identified between bronchiolitis and childhood asthma. These findings contribute to a more comprehensive understanding of the complex interrelationships among AD, bronchiolitis, and the early onset of childhood asthma.CONCLUSIONThis study confirms that children under the age of 3 years who have early-onset AD are significantly more susceptible to recurrent wheezing and asthma. It is crucial to identify AD as a potential early indicator of childhood asthma. This knowledge can enhance awareness among health-care professionals and parents, leading to earlier detection of asthma symptoms in children. Ultimately, this can contribute to more effective management strategies for these young patients.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[The Antioxidant and Antibacterial Effects of Gambier Catechin (Uncaria gambir Roxb) in Streptococcal Gingivitis: A Review]]></title>
            <link>https://reference-global.com/article/10.3889/seejim.2024.6067</link>
            <guid isPermaLink="false">/article/10.3889/seejim.2024.6067</guid>
            <pubDate>Fri, 07 Jun 2024 00:00:00 GMT</pubDate>
            <description><![CDATA[BACKGROUNDOral health is very important for general health and well-being. Oral diseases such as caries and periodontitis are common throughout the world. Periodontal is the main cause of tooth loss in adults. This disorder begins with gingivitis (swelling of the gums due to plaque), which, if left untreated, will result in periodontitis or infection that can destroy the teeth and surrounding tissue. The current management of this disease is to give analgesia and antibiotics, but early prevention and treatment are needed, one of them by using toothpaste.AIMSThis study aims to assess the effectiveness of Gambier catechin as a preventive approach for streptococcal gingivitis.METHODSThe research design used is a literature review study conducted from preclinical and clinical studies extracted from indexed international journals. Studies from 2012 to 2022 in English and related to the keywords are reviewed and synthesized.RESULTSThe pathophysiology of the majority of gingivitis is related to inadequate cleaning of the oral cavity, which leads to the accumulation of plaque and bacteria. Catechins from Gambier also have a stronger capacity as antioxidants. Preclinical studies stated that Gambier has a strong potential for antioxidants. Catechins have stronger antioxidant capabilities than vitamins C and E. Catechins from Gambier also have a stronger capacity as antioxidants than vitamin E. Gambier catechin contains polyphenolic compounds that have antibacterial activity so that they can inhibit the formation of dental plaque. The catechin compound as an antibacterial has two properties, namely being able to inhibit (bacteriostatic) and kill (bacteria) the growth of bacteria.CONCLUSIONGambier catechin has antioxidant and antibacterial effects and has potential for treating streptococcal gingivitis.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[Toxic Epidermal Necrolysis: Case Report and Review]]></title>
            <link>https://reference-global.com/article/10.3889/seejim.2024.6075</link>
            <guid isPermaLink="false">/article/10.3889/seejim.2024.6075</guid>
            <pubDate>Fri, 07 Jun 2024 00:00:00 GMT</pubDate>
            <description><![CDATA[BACKGROUNDStevens–Johnson syndrome and toxic epidermal necrolysis (TEN) are severe mucocutaneous adverse drug reactions primarily caused by drugs. Characterized by fever, prodromal symptoms, and extensive epidermal sloughing with mucous membrane involvement (&gt;90%), they are collectively termed epidermal necrolysis and are considered a disease continuum.CASE PRESENTATIONA 65-year-old man presented with widespread erythema and distinctive target-like lesions, accompanied by ruptured flaccid vesicles on the extremities. Following a 4-week carbamazepine treatment for a previous cerebrovascular insult, hematological analysis revealed abnormalities. A multidisciplinary team, including a neurologist, endocrinologist, and ophthalmologist, prescribed a 3-day course of intravenous immunoglobulin at 0.5 g/kg and an initial dose of 300 mg prednisolone for 3 days, supported by additional therapy. Discharged after 3 weeks, the rash completely resolved within 2 months.CONCLUSIONTEN, a severe mucocutaneous condition with a 30% mortality rate, often results from drug exposure. Swift identification of the causative drug is crucial for optimal outcomes. Treatment primarily includes discontinuing the offending drug and offering supportive care for mucocutaneous lesions. A multidisciplinary approach is vital based on organ system involvement. The effectiveness of pharmacological treatments, such as intravenous immunoglobulin and corticosteroids, is continually under evaluation.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[The Effect of Nutritional Status on the Quality of Life of People with HIV/AIDS (ODHA) Receiving Antiretroviral Therapy]]></title>
            <link>https://reference-global.com/article/10.3889/seejim.2024.6062</link>
            <guid isPermaLink="false">/article/10.3889/seejim.2024.6062</guid>
            <pubDate>Fri, 07 Jun 2024 00:00:00 GMT</pubDate>
            <description><![CDATA[BACKGROUNDHuman immunodeficiency virus (HIV) is a type of virus that can weaken the immune system. People living with HIV (PLHIV) is vulnerable to a decrease in quality of life due to declining physical health and stigma from themselves and society. PLHIV is also found to have less intake, changes in the body’s metabolic rate, and changes in the digestive system, which results in malnutrition conditions.AIMThe aim of the study is to analyze the effect of nutritional status on the quality of life of people with HIV/acquired immunodeficiency syndrome (AIDS) (ODHA) receiving antiretroviral therapy (ARV).METHODSThis study was cross-sectional analytical study that examines nutritional status using body mass index with quality of life of PLHIV assessed by the World Health Organization Quality of life-HIV BREF questionnaire. Bivariate analysis was analyzed by Chi-square test and multivariate analysis by logistic regression test.RESULTSThe results of the study found no relationship between nutritional status and quality of life. This study found a relationship between age, stigma, and depression with quality of life in PLHIV who received ARVs.CONCLUSIONThe integration of psychologists in the treatment of HIV/AIDS is also recommended considering that depression plays a role in the quality of life of PLHIV. Counseling and health education to the community to reduce stigma should also be done.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[Unlocking Therapeutic Potential of Bengkoang (Pachyrhizus erosus) Inulin and Lactobacillus Synergies in Synbiotics for Immunomodulatory Interventions in Indonesia: A Review]]></title>
            <link>https://reference-global.com/article/10.3889/seejim.2024.6066</link>
            <guid isPermaLink="false">/article/10.3889/seejim.2024.6066</guid>
            <pubDate>Fri, 07 Jun 2024 00:00:00 GMT</pubDate>
            <description><![CDATA[BACKGROUNDIndonesia’s vision for 2045 encapsulates a grand aspiration for global competitiveness and resilience, with an emphasis on cultivating robust and skilled human capital. This study delves into the pivotal role of health-centric food and beverages as a fundamental component aligned with the Sustainable Development Goals 2030. The objective is to confront non-communicable diseases and preempt the anticipated surge in malnutrition-related fatalities projected for Indonesia’s population of 340 million by 2045. The findings illuminate the potential of synbiotics, specifically highlighting the synergistic relationship between Bengkoang inulin and Lactobacillus.METHODSConducted through a narrative literature review method, this research meticulously synthesized articles drawn from national and international journals published within the past decade. The rigorous selection criteria honed in on themes surrounding synbiotics, Pachyrhizus erosus, immunomodulators, inulin, and Lactobacillus. The chosen articles underwent comprehensive analysis and synthesis.RESULTSSynbiotics exhibited promising enzymatic activities, growth enhancements, and significant immune modulation. These outcomes signal substantive implications for disease prevention and overall health enhancement. The discussion emphasizes the potential application of synbiotics as a promising therapeutic intervention for malnutrition. It is underscored by its multifaceted impact on gut health, nutrient absorption, immune modulation, and its potential therapeutic applications across diverse health domains – the pivotal role of synbiotics in averting health disparities and augmenting overall well-being. The discussion delves into the immunomodulatory potential of synbiotics, elucidating their ability to fine-tune immune responses, mitigate inflammation, and potentially enhance vaccine efficacy.CONCLUSIONThis comprehensive analysis underscores the far-reaching implications of synbiotic therapy, positioning it as a promising avenue for therapeutic innovation and holistic health interventions.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[Ethylenediaminetetraacetic Acid-dependent Platelet Aggregation, Satellitism, and Phagocytosis in a Case in Which Aggregation was Resolved using Kanamycin Blood Collection Tubes]]></title>
            <link>https://reference-global.com/article/10.3889/seejim.2024.6072</link>
            <guid isPermaLink="false">/article/10.3889/seejim.2024.6072</guid>
            <pubDate>Fri, 07 Jun 2024 00:00:00 GMT</pubDate>
            <description><![CDATA[BACKGROUNDThis study aimed to investigate ethylenediaminetetraacetic acid (EDTA)-dependent pseudothrombocytopenia (EDTA-PTCP) a rare but significant phenomenon in clinical laboratories that cause diagnostic errors and unnecessary treatments.CASE PRESENTATIONHere, we present an 83-year-old male patient with dyspnea and blood sputum and illustrate how EDTA, commonly used in complete blood count testing, causes falsely low platelet counts due to platelet aggregation and phagocytosis. Initially, the patient’s blood tested by the impedance method with a Sysmex XN-3000 analyzer demonstrated abnormally low platelet counts. However, further tests using different assays (fluorescent platelet count) and anticoagulants indicated the presence of EDTA-PTCP. Blood smear revealed platelet aggregation, satellitism, and phagocytosis that predominantly involve neutrophils. Remeasurements demonstrated significant improvement in platelet count and histogram waveform after incorporating K2-EDTA-added blood to K2-EDTA + kanamycin (KM)-containing vacutainer. These results indicate that remeasuring platelet counts after dissociation of platelet aggregation in EDTA-added blood with an additive such as KM is an effective method of handling EDTA- PTCP when platelet aggregation is observed. In addition, in vitro mixing studies were conducted with healthy control using platelet-poor plasma (PPP), prepared from EDTA and EDTA + KM blood collection tubes. It demonstrated that adding PPP from EDTA + KM tubes to whole blood did not decrease platelet count over time, unlike PPP from EDTA tubes. This revealed that KM, an aminoglycoside antibacterial agent, inhibited platelet aggregating factors in the patient’s plasma. The patient’s positive results for anti-ds-DNAIgG antibodies indicated active systemic lupus erythematosus, emphasizing a potential immunological mechanism of EDTA-PTCP in autoimmune diseases.CONCLUSIONThe study reveals that EDTA causes platelet satellitism and phagocytosis by leukocytes, although the exact mechanism of EDTA-induced platelet phagocytosis remains unclear. In conclusion, this case demonstrates that using blood collection tubes other than those containing EDTA salt is a viable option in various laboratories, emphasizing the need for awareness and appropriate management of EDTA-PTCP in clinical practice.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[Drug Rash with Eosinophilia and Systemic Symptoms Syndrome: Case Report and Literature Review]]></title>
            <link>https://reference-global.com/article/10.3889/seejim.2024.6060</link>
            <guid isPermaLink="false">/article/10.3889/seejim.2024.6060</guid>
            <pubDate>Tue, 12 Mar 2024 00:00:00 GMT</pubDate>
            <description><![CDATA[BACKGROUNDDrug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome is a rare, potentially life-threatening, drug-induced hypersensitivity reaction. This condition is characterized by a range of symptoms, including cutaneous reaction, hematologic abnormalities, lymphadenopathy, and potential involvement of internal organs. Most DRESS cases are associated with certain medications such as antiseizure drugs, allopurinol, antibacterial sulfonamides, minocycline, and vancomycin.CASE PRESENTATIONWe presented a case of 70-year-old women exhibiting maculopapular rash affecting the face, abdomen, and extremities. She experienced generalized pruritus, along with ulcerative crusty lesions on the mouth and mucopurulent conjunctivitis, all of which had persisted for 1 week. She was recently diagnosed with hyperuricemia and had been undergoing treatment with allopurinol for 4 weeks. During her hospital stay, the rash intensified, and there was a worsening involvement of the mucosa in the oral and ocular area. Allopurinol was promptly discontinued, and the patient was prescribed a daily dose of 100 mg prednisolone, gradually tapering off over a 2-month period. Additionally, the treatment included anticoagulants, antibiotics, local application of mild steroid emulsions, antiseptic, and antifungal therapy for the oral mucosa. Antibiotic solutions and natural tear eye drops were used. Over the 2-month period, the rash completely resolved, and the liver enzymes returned to normal levels.CONCLUSIONDRESS syndrome is an unpredictable drug-induced reaction identified by symptoms such as rash, fever, lymphadenopathy, and potential internal organ involvement. Allopurinol is among the medications associated with this condition, particularly when there is a reduced renal clearance and simultaneous use of thiazide diuretics. Prompt withdrawal of the causative drug is the universally accepted approach to manage drug-induced hypersensitivity reactions. The use of systemic corticosteroids can reduce symptoms of delayed hypersensitivity reactions. However, the absence of randomized controlled trials leaves uncertainty about the necessity of administering steroids, sparking a controversial debate regarding their use in such cases.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[CAR-T Cells – Main Steps for Obtaining a Proper “Live Drug” Adoptive Therapy]]></title>
            <link>https://reference-global.com/article/10.3889/seejim.2024.6063</link>
            <guid isPermaLink="false">/article/10.3889/seejim.2024.6063</guid>
            <pubDate>Tue, 12 Mar 2024 00:00:00 GMT</pubDate>
            <description><![CDATA[Chimaeric antigen receptor (CAR) T lymphocytes (CAR-T) discovered in 1992 have been in the recent years in the spotlight of both researchers and clinicians. Immune therapy with engineered CAR-T cells has been approved by the FDA since 2017 for pediatric and young adult acute lymphoblastic leukemia. Since then, around ten therapies were approved for hematological cancers. In contrast to the other immune therapies CAR-T cell therapy is considered a “living drug” with the capacity of self-replicating. Having this particular characteristic, the manufacturing process has in general several steps that should be followed in the process of obtaining specific CAR-T cells. There are mandatory steps for obtaining a CAR-T cell culture: Leukapheresis, activation, gene delivery, expansion, and cryopreservation. All these seminal stages have various sub-stages that can differ from one procedure to other as detailed in the paper. Leukapheresis harvests peripheral blood mononuclear cells, followed by an enrichment of a certain cellular population or a depletion phase to remove contaminants as red blood cells and platelets. T cell population that is obtained needs to be activated using activating antibodies (Abs), magnetic beads coated with activating Abs or artificial antigen-presenting cells. After activation, T cells are subjected to genetic engineering that can be done using electroporation of naked DNA, plasmids, or viral vectors to insert the specific CAR. The last phases of CAR-T cell manufacturing are the expansion of these specific cells and, if not freshly inoculated to the patients, the final step is cryopreservation. The main drawback of CAR-T cell therapy is its high cost; therefore, new automated platforms would decrease their cost. The described stages are still variable within CAR-T manufacturing. Therefore, the future of this immune therapy will have to tackle standardization and automated technology, directions that will increase healthcare system availability.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[Prevalence and Characteristics of Allergic Asthma in a Sample of Dairy Farmers]]></title>
            <link>https://reference-global.com/article/10.3889/seejim.2024.6065</link>
            <guid isPermaLink="false">/article/10.3889/seejim.2024.6065</guid>
            <pubDate>Tue, 12 Mar 2024 00:00:00 GMT</pubDate>
            <description><![CDATA[AIMThe objective of the study is to evaluate the prevalence characteristics of allergic asthma in a sample of dairy farmers.METHODSWe performed a cross-sectional study including 83 dairy farmers (mean age: 52.6 ± 8.7 years; mean exposure duration: 23.7 ± 7.6 years) compared to 80 office controls (mean age: 52.7 ± 8.2 years) matched for age, smoking habits, and socioeconomic status. Methods of evaluating examined subjects included a questionnaire on respiratory symptoms in the past 12 months, baseline spirometry and histamine challenge, and skin prick tests to standard inhalant and occupational allergens.RESULTSThe frequency of asthma was non-significantly higher in dairy farmers than in controls (7.2% vs. 5%). The frequency of allergic asthma was non-significantly higher in dairy farmers than in controls (6% vs. 3.8%). The frequency of allergic asthma was significantly higher compared to non-allergic asthma in both groups, while the frequency of subjects with allergic asthma who are sensitized to occupational allergens (wheat, corn, rye, cow hairs, molds) was similar in dairy farmers and controls. The risk of sensitization to occupational allergens was non-significantly higher among dairy farmers with allergic asthma (OR = 1,39 [0,18–12,28] CI 95%), compared to office controls. The risk for asthma development was non-significantly higher in subjects sensitized to occupational allergens compared to those who are not sensitized to them both in dairy farmers (OR = 2.00 [0.11–40.60] CI 95%) and office controls (OR = 3.00 [0.00–197.11] CI 95%). The risk for asthma development was about 4 times higher in subjects with atopy compared to those without atopy among dairy farmers (OR = 4.00 [0.22–104.88] CI 95%), while in office controls was almost identical (OR = 1.00 [0.00–39.77] CI 95%). Having in mind sensitization to certain inhalant allergens, asthma was significantly associated with sensitization to Dermatophagoides pteronyssinus both in dairy farmers (p &lt; 0.01) and office controls (p &lt; 0.05).CONCLUSIONThe results suggest that occupational exposure among dairy farmers was associated with a higher prevalence respiratory symptoms, lung function impairment, and allergic asthma development. Study findings also can contribute in the detection of critical points for action, predict asthma development, and indicate the need for reduction of adverse occupational exposures by appropriate preventive measures, use of respiratory protective equipment, and implementation of engineering controls.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[Deviation in White Blood Cell Count Measurement between WNR and WDF Channels on an Automated Hematology Analyzer XN-3000: A Case Report]]></title>
            <link>https://reference-global.com/article/10.3889/seejim.2024.6059</link>
            <guid isPermaLink="false">/article/10.3889/seejim.2024.6059</guid>
            <pubDate>Tue, 12 Mar 2024 00:00:00 GMT</pubDate>
            <description><![CDATA[BACKGROUNDAt present, complete blood count (CBC) testing is one of the most common clinical tests. The XN-3000 used in our hospital utilizes the principles of impedance and semiconductor laser flow cytometry, which contains two types of leukocyte fractionation methods: White cell nucleated (WNR) and white cell differential (WDF) channels.CASE PRESENTATIONHerein, we present the case of a 63-year-old male patient who was admitted to our hospital for the treatment of non-small cell lung cancer (T4N3M1 [LYM, HEP, and OSS]). Biochemical data showed abnormal liver function and anemia. WNR results showed poor leukocyte and debris fractions compared with WDF results, and leukocyte counts were different between the two channels. However, the poor fractionation of the leukocyte and debris fractions in the WNR was resolved at the twofold dilution stage. To investigate the cause of the problem, precipitates affecting the WNR measurement were visually checked. Consequently, insoluble precipitates were observed in the WNR mixture of the specimen of the patient. In our hospital, we measure 1200 CBCs/day and very rarely encounter abnormal specimens such as in the presented case. Normally, leukocyte counts are reported in priority to those measured by the WNR channel; however, in this case, the switching function was effective in giving priority to WDF count results because of the appearance of abnormal WNR plots. However, a system that can promptly confirm events when results are reported is necessary.CONCLUSIONWe very rarely encounter abnormal specimens such as in the presented case. Normally, leukocyte counts are reported in priority to those measured by the WNR channel; however, in this case, the switching function was effective in giving priority to WDF count results because of the appearance of abnormal WNR plots. However, a system that can promptly confirm events when results are reported is necessary. When no clinical request for WDF measurement was made, the WNR scattergram must be confirmed, dilution measurement, if necessary, must be performed, or the WDF must be measured and reported to the clinician as useful criteria for diagnosis.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[Efficacy of Nilavembu Kudineer for Dengue Fever Management – An Overview of Clinical and Preclinical Evidences]]></title>
            <link>https://reference-global.com/article/10.3889/seejim.2023.6058</link>
            <guid isPermaLink="false">/article/10.3889/seejim.2023.6058</guid>
            <pubDate>Wed, 03 Jan 2024 00:00:00 GMT</pubDate>
            <description><![CDATA[BACKGROUND AND AIMDengue viral disease (DVD) is a tropical arboviral disease that is caused by dengue virus (DENV), which is transmitted mainly by the bite of female Aedes aegypti mosquitoes. No specific antiviral drug is approved yet to manage the patients with DENV infection, who are managed using symptomatic therapy and supportive care.AIMAs a consequence, we intend to review the potential of Nilavembu kudineer in the management of DENV infection.MATERIALS AND METHODSTo find articles pertinent to the clinical, in vitro, and in silico studies evaluating the effectiveness of Nilavembu Kudineer in the management of DENV infection, the literature was searched in databases such as Medline/PubMed Central/PubMed, Google Scholar, Science Direct, EBSCO, Scopus, Web of science, Embase, Directory of open access journals, and reference lists.RESULTSNilavembu Kudineer may be able to alleviate signs and symptoms experienced by patients with DENV infection, according to few clinical, in vitro, and in silico studies.CONCLUSIONThe effectiveness of Nilavembu Kudineer in patients with DENV infection would further be demonstrated by additional randomized controlled clinical trials.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[Advanced Platelet-rich Fibrin versus Sticky Bone in Socket Preservation - Clinical and X-ray Assessment: Case Report]]></title>
            <link>https://reference-global.com/article/10.3889/seejim.2022.6030</link>
            <guid isPermaLink="false">/article/10.3889/seejim.2022.6030</guid>
            <pubDate>Wed, 03 Jan 2024 00:00:00 GMT</pubDate>
            <description><![CDATA[BACKGROUNDThe preservation of post-extraction alveola, as part of guided bone regeneration, is recommended for the creation of a biological foundation for future implant-prosthetic or prosthetic production. Several graft materials are used, either independently or in a combination of each other. Advanced platelet-rich fibrin (A-PRF) as an autologous blood derivate in the recent years has been increasingly used because of its properties in angiogenesis, epithelialization, and hemostasis. Simple production, low cost, and non-use of anticoagulants are advantages for more mass use of it.CASE PRESENTATIONTwo clinical cases are described, one is using a combination of A-PRF with xenograft, and the second clinical case is using a solo A-PRF, for socket preservation.CONCLUSIONThe properties of A-PRF for preserving both bone volume and quality have been confirmed, highlighting its potential as a valuable therapeutic tool. Furthermore, the post-operative period following A-PRF treatment has been found to be free of significant discomfort and morbidity for patients, suggesting that this approach may represent a safe and effective means of promoting optimal clinical outcomes.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[Systemic Circulating Leptin – Aiding New Dimension of Immune-Related Skin Carcinogenesis and Lipid Metabolism]]></title>
            <link>https://reference-global.com/article/10.3889/seejim.2023.6024</link>
            <guid isPermaLink="false">/article/10.3889/seejim.2023.6024</guid>
            <pubDate>Wed, 03 Jan 2024 00:00:00 GMT</pubDate>
            <description><![CDATA[AIMThe link between the development of melanoma skin cancer and obesity is gaining recently an increased attention. A plethora of immune-related factors sustain a chronic inflammatory state modulated by the metabolic imbalance, the main examples being tumor necrosis factor alpha, interleukin 6, monocyte chemoattractant protein (MCP1), and several adipokines. Among the adipokines leptin (LEP) is steadily increasing interests as it involved in modulating different signaling pathways (e.g., JAK2/STAT3 and MAPK cascade/FOS) and immune cells fate by promoting the switch of memory cells to T helper-1 cell response, increases CD4+CD25- T-cell proliferation, and reduces autophagy during T-cell receptor stimulation. Our work investigates in a pilot study, using protein microarray technology, the LEP circulatory levels in melanoma patients in comparison to other cytokines and chemokines already reported as significantly involved in melanoma initiation and progression.METHODSSerum from melanoma cases and pool of serum from healthy volunteers were analyzed by an antibody array platform for a 42-cytokine profile.RESULTSThe investigation of cytokines, chemokines, and growth factors has shown that all the proinflammatory circulating molecules are elevated in the melanoma patient’s serum. Inflammatory cytokines were found elevated and were correlated to the more advanced stage of the investigated patient (M2). The highest circulatory level was registered for LEP in both melanoma cases; moreover, in M1 patient, although the LEP level was completely comparable with the one found in M2, its IL-1 serum level was normal. In addition, there are ten analytes that show clear abnormal values and in patient M2 high LEP concentration is correlated with high IL-1, MCP-2, MCP-3, MCSF, and TARC serum concentrations.CONCLUSIONLeptin is pleiotropic adipocytokine involved in various diseases, including skin cancer and melanoma. As it is involved in favoring inflammation and further tumorigenesis, the development of effective leptin-based therapeutic approaches opens new possibilities of adjuvant therapy in skin cancers.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[The Effectiveness of the Influence of the Second Generation Platelet-rich Fibrin in the Treatment of Localized Individual Miller I and II Gingival Recessions (Case Report)]]></title>
            <link>https://reference-global.com/article/10.3889/seejim.2023.6038</link>
            <guid isPermaLink="false">/article/10.3889/seejim.2023.6038</guid>
            <pubDate>Wed, 03 Jan 2024 00:00:00 GMT</pubDate>
            <description><![CDATA[BACKGROUNDThe mucogingival surgical modality subepithelial connective tissue graft (SCTG) and the coronally positioned flap (CAF) in the treatment of Miller I and II gingival recessions are considered “gold standard,” that is, a technique for predictable and complete gingival root coverage defects, with long-term clinical stability of the obtained results. The counterpart of this type of technique is the relatively young platelet-rich fibrin (PRF) +CAF operational mode, due to the biological characteristics of this autologous platelet concentrate-PRF (angiogenesis, mitogenesis, osteopromotion, immunomodulation, and the capture of stem cells). The aim of this paper is to evaluate the clinical efficacy of the CAF+PRF combined technique, in the treatment of localized individual gingival recessions Miller I and II, through the comparison of the values of periodontal clinical parameters, measured preoperatively and 1 month postoperatively, as well as through the obtained immunohistochemical and histomorphometric analyzes of the taken biopsy material from the recipient site (the area of the grafted gingival defect), 1 month postoperatively.CASE REPORTA 37-year-old man was admitted to the Clinic for Oral Surgery at JZU USKC “St. Panteleimon”-Skopje for surgical treatment of localized maxillary gingival recession Miller II at tooth 31. Periodontal clinical parameters were measured preoperatively: Vertical dimension of gingival recession (RD/VGR), periodontal pocket depth (PPD/PD), level of keratinized/attached gingiva (CAL), width of keratinized gingiva (KTW/KMW) and thickness of gingiva (GT), all measured in mm, as well as gingival biotype. A CAF+PRF therapy modality was used for the treatment of the gingival defect. One month postoperatively, repeated measurements of the values of the clinical periodontal indices were performed and they were compared with the measurements obtained preoperatively.CONCLUSIONA significant decrease in the values of RD, PPD, and CAL was determined at the 1-month measurements postoperatively. A non-significant gain in KTW and GT values was noted 1 month post-operative. There were no changes in the gingival biotype before and after surgery. PRF as second-generation autologous concentrates is not only an adjuvant and/or replacement of SCTG – the “gold standard” in the treatment of Miller I and II recessions but it is also a superior alternative in the surgical treatment of this type of shallow mucogingival defects.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[Risk Factors for Human Immunodeficiency Virus: Blood Transfusion, Injecting Drug Use, Piercing, and Tatto in Indonesia]]></title>
            <link>https://reference-global.com/article/10.3889/seejim.2023.6034</link>
            <guid isPermaLink="false">/article/10.3889/seejim.2023.6034</guid>
            <pubDate>Wed, 03 Jan 2024 00:00:00 GMT</pubDate>
            <description><![CDATA[BACKGROUND:Human immunodeficiency virus (HIV) is still a public health problem worldwide. HIV transmission occurs through several modes of transmission. One of the intermediaries for transmission is through blood transfusions, IDU (injecting drug use) with sharing needles or not (sterile), especially among injecting drug users, as well as piercing and tattoos.AIMThe purpose of the study was to analyze risk factors for HIV: Blood transfusion, IDU, piercing, and tatto in Indonesia.METHODSThe research design was cross-sectional. The population of all individuals with HIV who are included in the blood transfusion, IDU, piercing, and tattoo users at the Kompeda City Surabaya Foundation is 183 people with 100 respondence using simple random sampling technique. The instrument used is a questionnaire. The data were analyzed by double linear regression test.RESULTSThe results of multivariate analysis showed that blood transfusion (p = 0.01), injecting drug use (p = 0.00), piercing (p = 0.01), and tattoo (p = 0.01) factors significantly influenced the incidence of HIV. R Square of the five factors is 0.000.CONCLUSIONRisk factors such as blood transfusions, injecting drug use (IDU), piercings, and tattoos are factors that cause HIV. Preventive efforts can be made to prevent HIV risk factors through education by implementing the health promotion model about HIV/AIDS as well as prevention and transmission that can suppress the spread of HIV/AIDS.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[Assessment of Serum Soluble CD30 Levels in Pediatric Kidney Transplant Recipients]]></title>
            <link>https://reference-global.com/article/10.3889/seejim.2023.6057</link>
            <guid isPermaLink="false">/article/10.3889/seejim.2023.6057</guid>
            <pubDate>Wed, 03 Jan 2024 00:00:00 GMT</pubDate>
            <description><![CDATA[BACKGROUNDCD30 is considered to be a marker for the activated immune system; however, its association with acute rejection and kidney graft function showed severe heterogeneity.AIMThe aim of this study is to examine the predictive value of soluble CD30 (sCD30) levels for kidney transplantation (KT) outcomes in children.MATERIALS AND METHODSCD30 in serum was measured by ELISA technique in 50 pediatric kidney transplant recipients (KTRs) within 13.4 ± 4.5 days before and within 19.5 ± 9.2 days after KT. sCD30 values were correlated with clinical, laboratory, and immunosuppressive (IS) therapy data and graft function of included patients. Twenty age/gender-matched healthy controls participated as reference values for sCD30 levels.RESULTSOur study revealed that serum levels of CD30 showed a significant relation between serum sCD30 levels: Pre/post-transplantation (p = 0.02) with increasing sCD30 levels after transplantation (71.60 pg/mL vs. 90.20 pg/mL). In the time, there were no relations between sCD30 with other parameters.CONCLUSIONSOur results suggest that the measurement of serums CD30 levels may be used as a valuable biomarker in renal transplantation when it is measured pre/post-transplantation.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[Incidence of Immunological Occupational Asthma in 2015–2022 by Occupation: Macedonian Experience]]></title>
            <link>https://reference-global.com/article/10.3889/seejim.2023.6027</link>
            <guid isPermaLink="false">/article/10.3889/seejim.2023.6027</guid>
            <pubDate>Wed, 03 Jan 2024 00:00:00 GMT</pubDate>
            <description><![CDATA[BACKGROUNDImmunologic occupational asthma (OA), a more prevalent OA type than non-immunologic OA, became an important public health problem in the last decades worldwide.AIMTo present the distribution of new diagnosed cases of immunologic OA in the RN Macedonia in the period 2015–2022 by occupation.METHODSImmunologic OA was diagnosed by the serial measurement of peak expiratory flow rate (PEFR) at and away from work or by combination of serial PEFR measurement at and away from work and non-specific bronchial provocation at and away from work in workers with diagnosed asthma and work-relatedness of the symptoms. Sensitization to common inhalant and occupational allergens was evaluated by skin prick test.RESULTSThe annual incidence rate of the diagnosed immunologic OA in this period varied from 1.9 / 100,000 working population in 2015–2.6 / 100,000 in 2022 with a drop in 2020 and 2021, i.e. in the period of COVID-19 pandemic (0.6 and 0.5, respectively). Cleaning, bakery, cleaning, textile manufacture, wood industry, agriculture, and metal-parts manufacture were the most important occupations for the development of immunologic OA. More than a half of the new diagnosed immunologic OA cases were atopics.CONCLUSIONOur findings indicated the occupations with the highest incidence of immunologic OA that could enable targeting of preventive measures and activities to reduce the occurrence of immunologic OA as well as its adverse health outcomes.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[Anti-inflammatory Effect of Gambier Catechin (Uncaria gambir Roxb) on Rheumatoid Arthritis: A Review]]></title>
            <link>https://reference-global.com/article/10.3889/seejim.2023.6055</link>
            <guid isPermaLink="false">/article/10.3889/seejim.2023.6055</guid>
            <pubDate>Wed, 03 Jan 2024 00:00:00 GMT</pubDate>
            <description><![CDATA[BACKGROUNDRheumatoid arthritis (RA) is a chronic inflammatory disease of the joints and varies in severity in patients. Inflammation in the joints causes high levels of systemic pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) which have an impact on permanent damage to the joints. Until now, the treatment of RA is only symptomatic, without being able to prevent the progression of damage to the joints, and this treatment also causes side effects such as gastrointestinal and cardiovascular toxicity. Therefore, many patients are looking for alternative medicine to complement their treatment.METHODSThis research was a narrative review that was performed using PubMed, Science Direct, and Google Scholar using pre-clinical and clinical studies which aim to determine whether the therapeutic mechanism of gambier catechin (Uncaria gambir Roxb) on RA. A literature review is carried out to formulate a scientific basis for innovation.RESULTSThe gambier plant is a typical plant of West Sumatra, which is rich in phytochemicals. The active compounds in gambier are catechins which are classified as flavanols/flavonoids. Catechins are compounds that are well-known as antioxidant, anti-inflammatory compounds, the highest found in gambier plants. Catechins affect the expression of inflammation-related genes and proteins such as TNF-α, IL-1, and show their anti-inflammatory roles. This research is a literature review using secondary data from original research based on in vitro, in vivo, and clinical trials. The results showed that catechins can inhibit the production of IL-1, TNF-α, prostaglandin and increase levels of cyclic adenosine monophosphate in rats. On histological findings, peri-synovial inflammation and cartilage damage decreased in the group given epigallocatechin-3-gallate which showed anti-rheumatic activity and increased CD4+ and CD25+ regulatory T cells, thereby inhibiting the B cell population effectively suppresses inflammation and arthritis pain and shows its therapeutic potential in the treatment of RA.CONCLUSIONIt can be concluded that gambier catechins have the potential as a candidate for RA therapy. This, if developed, can certainly improve the health status of the community locally and globally.]]></description>
            <category>ARTICLE</category>
        </item>
        <item>
            <title><![CDATA[SARS-COV-2 Infection and Reproductive Capacity: What do we know after the Pandemic?]]></title>
            <link>https://reference-global.com/article/10.3889/seejim.2023.6046</link>
            <guid isPermaLink="false">/article/10.3889/seejim.2023.6046</guid>
            <pubDate>Wed, 03 Jan 2024 00:00:00 GMT</pubDate>
            <description><![CDATA[Whether and in what way the infection could affect reproductive capacity in the long-term is a question that preoccupies not only doctors but also patients. The SARS-COV-2 virus affected their function through angiotensin converting receptor-2 and other receptors that are present in the tissues of female and male reproductive organs. It was noticed that men suffering from the infection have a reduced number of spermatozoa in the acute phase of the disease as well as in convalescence. The level of testosterone also plays a role in the impact of infection, which explains the more severe forms of the disease in older men and those with hypogonadism. Infection with SARS-COV-2 affects women’s fertility through the direct impact of on ovarian function, sex hormone production, and endometrial receptivity, but also through the impact of stress that pandemic infection can cause by affecting the function of the hypothalamic-pituitary-ovarian axis. Speculations about the impact of the vaccine on the reproductive capacity of young women were the reason why a large number of young people did not opt for the vaccine. Menstrual disorders, reduced sperm concentration, premature ovarian failure, erectile dysfunction, and anorgasmia are mentioned today as long-term effects of infection with the SARS-COV-2 virus. Despite numerous published studies on the impact of SARS-COV-2 on the reproductive function, it is still not possible to talk about the real long-term impact of the infection, but most of the data we have so far suggest that the impact of the infection was temporary except in rare cases.]]></description>
            <category>ARTICLE</category>
        </item>
    </channel>
</rss>